Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2001, p. 376-384, Vol. 8, No. 2
Infectious
Diseases
Received 20 June 2000/Returned for modification 20 September
2000/Accepted 11 December 2000
Borrelia burgdorferi, the agent of Lyme
borreliosis, is genetically more heterogeneous than previously
thought. In Europe five genospecies have been described from
the original B. burgdorferi sensu lato (sl): B. burgdorferi sensu stricto (ss), B. garinii, B. afzelii,
B. lusitaniae, and B. valaisiana. In the United
States, B. burgdorferi ss as well as B. bissettii in California and B. andersonii on the East
Coast were differentiated. In Asia, B. japonica has been
identified along, with B. garinii, B. afzelii, and B. valaisiana. In order to evaluate sensitivity and specificity of
four species-specific monoclonal antibodies, we analyzed 210 B. burgdorferi sl isolates belonging to eight genospecies
by immunoblot and confirmed genospecies by restriction fragment length
polymorphism (RFLP) of rrf (5S)-rrl (23S)
intergenic spacer amplicon. Monoclonal antibody H3TS had 100%
sensitivity for 55 B. burgdorferi ss isolates but
showed reactivity with all four isolates belonging to B. bissetii. Monoclonal antibody I 17.3 showed 100%
specificity and sensitivity for 45 B. afzelii isolates.
Monoclonal antibody D6 was 100% specific for
B. garinii but missed 1 of 64 isolates (98.5%
sensitivity). Monoclonal antibody A116k was 100% specific for
B. valaisiana but was unreactive with 4 of 24 isolates (83.5% sensitivity). Genetic analysis correlated well with
results of reactivity and confirmed efficacy of the phenotypic typing
of these antibodies. Some isolates showed atypical RFLP. Therefore,
both phenotypic and genotypic analyses are needed to characterize new
Borrelia isolates.
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.376-384.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Specificities and Sensitivities of Four Monoclonal
Antibodies for Typing of Borrelia burgdorferi Sensu
Lato Isolates
Immunology1 and DNA
Laboratory,2 Institut Central des
Hôpitaux Valaisans, CH-1950 Sion, Switzerland
*
Corresponding author. Mailing address: Infectious
diseases and Immunology, Institut Central des Hôpitaux Valaisans,
CH-1950 Sion, Switzerland. Phone: 41 27 603 47 90. Fax: 41 27 603 48 93. E-mail: olivier.peter{at}ichv.vsnet.ch.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |